Key facts
- PetMed projects $6.1 million in annualized savings.
- The company will remain independent.
- Previous proposals for the company ranged between $4 and $4.25 per share.
PetMed has announced projections of $6.1 million in annualized savings, signaling its intention to continue operating as an independent entity. This strategic decision was made in the context of prior proposals that had suggested a valuation range between $4 and $4.25 per share. The company's focus on internal efficiencies and cost-saving measures appears to be a key factor in its decision to forgo external offers and pursue a path of self-sufficiency.